Reining in drug cost regardless of who is president

Despite the presidential outcomes, we in the healthcare industry will still be faced with a heavy issue: how to go about reining in drug costs. Focus on adherence in real-world conditions. Our C the Cure program for a cohort of hepatitis C patients co-infected with...